CIPLA Financial Statement Analysis
|
||
The Revenues of CIPLA have increased by 13.28% YoY .
The Earnings Per Share (EPS) of CIPLA has increased by 47.08 % YoY. |
REVENUES |
OPERATING MARGIN |
PROFIT AFTER TAX |
EPS |
ROCE |
CIPLA Last 5 Annual Financial Results
[BOM: 500087|NSE : CIPLA]
Consolidated | Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 |
---|---|---|---|---|---|
Revenues | ₹25,774 Cr | ₹22,753 Cr | ₹21,763 Cr | ₹19,160 Cr | ₹17,132 Cr |
Expenses | ₹19,483 Cr | ₹17,763 Cr | ₹17,251 Cr | ₹14,911 Cr | ₹13,951 Cr |
Operating Profit (Excl OI) | ₹6,291 Cr | ₹4,990 Cr | ₹4,512 Cr | ₹4,249 Cr | ₹3,181 Cr |
Other Income | ₹747 Cr | ₹512 Cr | ₹322 Cr | ₹270 Cr | ₹369 Cr |
Interest | ₹90 Cr | ₹110 Cr | ₹106 Cr | ₹161 Cr | ₹197 Cr |
Depreciation | ₹1,051 Cr | ₹1,172 Cr | ₹1,052 Cr | ₹1,068 Cr | ₹1,175 Cr |
Profit Before Tax | ₹5,702 Cr | ₹4,038 Cr | ₹3,493 Cr | ₹3,290 Cr | ₹2,178 Cr |
Profit After Tax | ₹4,155 Cr | ₹2,835 Cr | ₹2,559 Cr | ₹2,401 Cr | ₹1,547 Cr |
Consolidated Net Profit | ₹4,122 Cr | ₹2,802 Cr | ₹2,517 Cr | ₹2,405 Cr | ₹1,547 Cr |
Earnings Per Share (Rs) | ₹51.05 | ₹34.71 | ₹31.19 | ₹29.82 | ₹19.18 |
PAT Margin (%) | 11.73 | 9.17 | 8.61 | 8.51 | 5.70 |
ROE(%) | 16.63 | 12.85 | 13.10 | 14.13 | 10.09 |
ROCE(%) | 22.77 | 18.19 | 17.24 | 17.85 | 12.53 |
Total Debt/Equity(x) | 0.01 | 0.02 | 0.04 | 0.10 | 0.18 |
Key Financials |
||
Market Cap | : | ₹ 119,702.5 Cr |
Revenue (TTM) | : | ₹ 26,981.2 Cr |
Net Profit(TTM) | : | ₹ 5,000.4 Cr |
EPS (TTM) | : | ₹ 61.9 |
P/E (TTM) | : | 23.9 |
Industry Peers & Returns | 1W | 1M | 1Y |
CIPLA | 2.2% | 3.9% | 2.3% |
SUN PHARMACEUTICAL INDUSTRIES | 0.5% | -3.4% | 13.4% |
DR REDDYS LABORATORIES | -1.5% | -7% | -5% |
ZYDUS LIFESCIENCES | -2.3% | -7.4% | 3.7% |
DIVIS LABORATORIES | -2.2% | 0.3% | 58.8% |
MANKIND PHARMA | -1.4% | -6.9% | 5.9% |
TORRENT PHARMACEUTICALS | -0.6% | -3.5% | 16.5% |
LUPIN | -0.6% | -4.3% | 25% |
AUROBINDO PHARMA | 1.7% | -1.9% | 13.2% |
CIPLA Revenues
[BOM: 500087|NSE : CIPLA]
Y-o-Y | 13.28 % |
5 Yr CAGR | 10.75 % |
Years | Revenues | % Change | |
---|---|---|---|
Mar2024 | ₹25,774 Cr | 13.28 | |
Mar2023 | ₹22,753 Cr | 4.55 | |
Mar2022 | ₹21,763 Cr | 13.59 | |
Mar2021 | ₹19,160 Cr | 11.84 | |
Mar2020 | ₹17,132 Cr | - |
CIPLA Operating Profit
[BOM: 500087|NSE : CIPLA]
Y-o-Y | 26.07 % |
5 Yr CAGR | 18.59 % |
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2024 | ₹6,291 Cr | 26.07 | |
Mar2023 | ₹4,990 Cr | 10.60 | |
Mar2022 | ₹4,512 Cr | 6.20 | |
Mar2021 | ₹4,249 Cr | 33.57 | |
Mar2020 | ₹3,181 Cr | - |
Operating Margins | |
---|---|
Y-o-Y | 11.31 % |
5 Yr CAGR | 7.08 % |
Years | Operating Margin% | % Change | |
---|---|---|---|
Mar2024 | 24.41% | 11.31 | |
Mar2023 | 21.93% | 5.79 | |
Mar2022 | 20.73% | -6.54 | |
Mar2021 | 22.18% | 19.44 | |
Mar2020 | 18.57% | - |
CIPLA Profit After Tax
[BOM: 500087|NSE : CIPLA]
Y-o-Y | 47.10 % |
5 Yr CAGR | 27.77 % |
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2024 | ₹4,122 Cr | 47.10 | |
Mar2023 | ₹2,802 Cr | 11.33 | |
Mar2022 | ₹2,517 Cr | 4.65 | |
Mar2021 | ₹2,405 Cr | 55.50 | |
Mar2020 | ₹1,547 Cr | - |
PAT Margins | |
---|---|
Y-o-Y | 27.92 % |
5 Yr CAGR | 19.77 % |
Years | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2024 | 11.73 % | 27.92 | |
Mar2023 | 9.17 % | 6.50 | |
Mar2022 | 8.61 % | 1.18 | |
Mar2021 | 8.51 % | 49.30 | |
Mar2020 | 5.7 % | - |
CIPLA Earnings Per Share (EPS)
[BOM: 500087|NSE : CIPLA]
Y-o-Y | 47.08 % |
5 Yr CAGR | 27.73 % |
Years | EPS | % Change | |
---|---|---|---|
Mar2024 | ₹51 | 47.08 | |
Mar2023 | ₹35 | 11.29 | |
Mar2022 | ₹31 | 4.59 | |
Mar2021 | ₹30 | 55.47 | |
Mar2020 | ₹19 | - |
CIPLA Return on Capital Employed (ROCE)
[BOM: 500087|NSE : CIPLA]
Y-o-Y | 25.18 % |
5 Yr CAGR | 16.11 % |
Years | ROCE | % Change | |
---|---|---|---|
Mar2024 | 22.77% | 25.18 | |
Mar2023 | 18.19% | 5.51 | |
Mar2022 | 17.24% | -3.42 | |
Mar2021 | 17.85% | 42.46 | |
Mar2020 | 12.53% | - |
CIPLA Share Price vs Sensex
Current Share Price | : | ₹1,482.2 |
Current MarketCap | : | ₹ 119,702.5 Cr |
Updated EOD on | : | Feb 18,2025 |
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CIPLA | 2.2% |
3.9% |
2.3% |
SENSEX | -0.4% |
-1.4% |
5.4% |
CIPLA related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
S&P BSE CARBONEX | 1.5% | 1.4% | 34.5% |
S&P BSE GREENEX | 0.9% | 1.7% | 52.5% |
S&P BSE 100 ESG INDEX | -0.5% | -1.1% | 6.7% |
S&P BSE SENSEX50 | -0.6% | -2.2% | 4.4% |
S&P BSE DIVIDEND STABILITY | -0.8% | -5.6% | -4.8% |
NSE Indices | 1W | 1M | 1Y |
---|---|---|---|
NIFTY GROWTH SECTOR 15 | 1.2% | 11.6% | 9.1% |
NIFTY100 LOW VOLATILITY 30 | -0.1% | -1.4% | 4.9% |
NIFTY50 EQUAL WEIGHT | -0.4% | -2% | 3.1% |
NIFTY 50 | -0.6% | -1.7% | 4.7% |
NIFTY HEALTHCARE | -0.7% | -4.7% | 13.1% |
You may also like the below Video Courses
FAQ about CIPLA Financials
How the annual revenues of CIPLA have changed ?
The Revenues of CIPLA have increased by 13.28% YoY .
How the Earnings per Share (EPS) of CIPLA have changed?
The Earnings Per Share (EPS) of CIPLA has increased by 47.08 % YoY .
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs